Superior Group (SGC) Stock Dips While Market Gains: Key Facts
The uniform maker's stock has climbed by 11.5% in the past month, exceeding the Consumer Discretionary sector's gain of 4.6% and the S&P 500's gain of 5.71%.
Investors will be eagerly watching for the performance of Superior Group in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on August 5, 2025. On that day, Superior Group is projected to report earnings of $0.05 per share, which would represent year-over-year growth of 25%. Meanwhile, our latest consensus estimate is calling for revenue of $134.2 million, up 1.86% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of $0.41 per share and revenue of $559.79 million, which would represent changes of -43.84% and -1.04%, respectively, from the prior year.
Investors should also take note of any recent adjustments to analyst estimates for Superior Group. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Currently, Superior Group is carrying a Zacks Rank of #3 (Hold).
Digging into valuation, Superior Group currently has a Forward P/E ratio of 27.89. This valuation marks a premium compared to its industry average Forward P/E of 15.52.
We can additionally observe that SGC currently boasts a PEG ratio of 2.79. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. By the end of yesterday's trading, the Textile - Apparel industry had an average PEG ratio of 2.07.
The Textile - Apparel industry is part of the Consumer Discretionary sector. With its current Zacks Industry Rank of 227, this industry ranks in the bottom 9% of all industries, numbering over 250.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Superior Group of Companies, Inc. (SGC) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Wolfe Research Sticks to Its Buy Rating for Sotera Health (SHC)
In a report released today, Michael Polark from Wolfe Research maintained a Buy rating on Sotera Health, with a price target of $17.00. The company's shares closed today at $13.97. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Polark is a 4-star analyst with an average return of 6.5% and a 50.31% success rate. Polark covers the Healthcare sector, focusing on stocks such as Insulet, Medtronic, and Steris. In addition to Wolfe Research, Sotera Health also received a Buy from Barclays's Luke Sergott in a report issued today. However, on August 1, TR | OpenAI – 4o reiterated a Hold rating on Sotera Health (NASDAQ: SHC). Based on Sotera Health's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $254.52 million and a GAAP net loss of $13.26 million. In comparison, last year the company earned a revenue of $248.18 million and had a net profit of $6.32 million
Business Insider
2 hours ago
- Business Insider
Figma's Historic IPO Surge Crashes Back to Reality
Figma stock (FIG) has seen a sharp reversal since its record-breaking IPO. Indeed, it lost about $21 billion in market value just days after going public. The San Francisco-based design software company opened at $85 on July 31, but its shares have been trading above and below that level all week. Interestingly, Figma saw a historical debut, as its shares jumped 250% on day one. This was the biggest in at least three decades for a U.S.-listed company that raised more than $1 billion, according to Bloomberg. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The momentum briefly continued to push the stock as high as $142.92 on Aug. 1, more than four times its IPO price. However, shares have since dropped to around $78. Analysts, like Steve Sosnick of Interactive Brokers (IBKR), note that such moves show the market's speculative nature, with interest likely to fade if shares remain below the opening price. He also pointed out that only 7% of Figma's shares were available to trade, thereby creating a shortage that drove prices up quickly before demand cooled. Despite the pullback, Figma's valuation remains high at roughly 37 times sales, which is far higher than peers. For context, if comparing to companies that are in the S&P 500 (SPY), only Palantir Technologies (PLTR), with a ratio above 90 times estimated sales, is higher. Other recent IPOs such as CoreWeave (CRWV) and Circle Internet Group (CRCL) also saw explosive early gains before losing more than 30% from their highs, but Figma's rapid surge and steep drop make it one of the most dramatic stock debuts of the year. Is FIG Stock a Good Buy? Overall, analysts see Figma as a high-growth SaaS firm with strong gross margins and retention rates. Although some are cautious about its valuation, most see its product stickiness as a key advantage in its market. As a result, investors expect it to continue growing.
Business Insider
2 hours ago
- Business Insider
Citi Sticks to Their Buy Rating for Zai Lab (ZLAB)
In a report released today, Yigal Nochomovitz from Citi maintained a Buy rating on Zai Lab, with a price target of $69.00. The company's shares closed today at $34.96. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Nochomovitz covers the Healthcare sector, focusing on stocks such as Arcturus Therapeutics, Sarepta Therapeutics, and Zai Lab. According to TipRanks, Nochomovitz has an average return of 5.2% and a 40.00% success rate on recommended stocks. In addition to Citi, Zai Lab also received a Buy from Jefferies's Michael Yee in a report issued on July 24. However, today, Bank of America Securities reiterated a Hold rating on Zai Lab (NASDAQ: ZLAB). ZLAB market cap is currently $4.38B and has a P/E ratio of -13.66. Based on the recent corporate insider activity of 46 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ZLAB in relation to earlier this year. Most recently, in May 2025, Scott W Morrison, a Director at ZLAB sold 23,799.00 shares for a total of $714,921.96.
